Online Program

Oral

Statistics for tobacco use in the US have stagnated and are considered to be at high risk for increasing. This is largely due to continued advertising and marketing by tobacco companies and a new emphasis on non-traditional/novel tobacco products (NTPs) such as snus, hookah/shisha, vapes, and gums. Unfortunately, those targeted are mostly youth, which leads to a disproportionately high burden of disease (due to their young age) and a potentially devastating toll on other health, economic, and productivity indicators. APHA’s 143rd meeting in Chicago is the ideal venue to discuss this important issue and develop essential policy steps. There is enthusiasm for this issue among APHA sections including ATOD and International Health, as the issue spans domestic and international areas. This panel will include high level participation from the American Medical Association, the FDA, The Ochsner Clinic and the American Lung Association. This issue is timely and critical. Best practices and next steps will be shared with the audience and active participation from attendees will be encouraged.

Session Objectives: Define the extent of youth tobacco use nationally Describe ways to combat new threats such as vapes, snus and hookah Compare approaches presented by states as well as national associations.

CE Credits: Medical (CME), Health Education (CHES), Nursing (CNE), Public Health (CPH)